Deep knowledge on 
 small-molecule drugs and 
 the 100,000 global patents 
 covering them 

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

How are People Using DrugPatentWatch?

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: ioflupane i-123

« Back to Dashboard
Ioflupane i-123 is the generic ingredient in one branded drug marketed by Ge Hlthcare Inc and is included in one NDA. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for Generic Name: ioflupane i-123

Tradenames:1
Patents:0
Applicants:1
NDAs:1
Drug Master File Entries: 0
Suppliers / Packaging: see list1

Clinical Trials for: ioflupane i-123

A Study to Assess Changes in Clinical Management After DaTSCAN Imaging of Subjects With Clinically Uncertain Parkinsonism or an Illness With Similar Symptoms
Status: Completed Condition: Parkinsonian Syndromes

Validation of DaTscan for Detection of Parkinson Disease Related Disorders
Status: Enrolling by invitation Condition: Parkinson Disease; Movement Disorders

DaTSCAN Imaging in Aging and Neurodegenerative Disease
Status: Enrolling by invitation Condition: Dementia; Parkinsonism; Mild Cognitive Impairment; REM Sleep Behavior Disorder

Compare Rates of Agreement Between Clinical Diagnosis and Visual Assessment of DaTscan™ Images in Non-Caucasian and Caucasian Subjects With Parkinson's Disease (PD) or Essential Tremor (ET)
Status: Active, not recruiting Condition: Essential Tremor; Parkinson's Disease

Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients With Different Genetic Characteristics
Status: Not yet recruiting Condition: Parkinson Disease

Imaging of Vesicular Acetylcholine and Dopamine Transporters in Dementia With Lewy Bodies
Status: Completed Condition: Dementia With Lewy Bodies

Co-LEsions in Alzheimer Disease and Related Disorders
Status: Not yet recruiting Condition: Alzheimer's Disease; Cerebrovascular Disease; Lewy Body Disease

Study of Dopamine and Serotonin Transporters in Patients With Amyotrophic Lateral Sclerosis and Controls
Status: Completed Condition: Amyotrophic Lateral Sclerosis

Dopaminergic Loss and Pain in Parkinson's Disease
Status: Completed Condition: Parkinson's Disease; Pain

DatScan With Prototype Collimator
Status: Recruiting Condition: Parkinson Disease

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Hlthcare Inc
DATSCAN
ioflupane i-123
SOLUTION;INTRAVENOUS022454-001Jan 14, 2011RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ioflupane i-123

These historical archives are available as an add-on to one-year subscriptions

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ge Hlthcare Inc
DATSCAN
ioflupane i-123
SOLUTION;INTRAVENOUS022454-001Jan 14, 20115,310,912<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc